JNJ - Johnson & Johnson
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$284.33
DETAILS
HIGH:
$320.00
LOW:
$260.00
MEDIAN:
$280.00
CONSENSUS:
$284.33
UPSIDE:
6.77%
About Johnson & Johnson (https://www.jnj.com)
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Joaquin Duato | Chief Executive Officer & Chairman | 1963 | $6,499,931 USD |
| Joseph J. Wolk | Executive Vice President & Chief Financial Officer | 1967 | $3,216,428 USD |
| John C. Reed | Executive Vice President of Innovative Medicine and R&D | 1958 | $3,165,384 USD |
| Timothy Schmid | Executive Vice President & Worldwide Chairman of MedTech | 1970 | $2,538,167 USD |
| Kristen Blair Mulholland | Executive Vice President & Chief Human Resources Officer | 1967 | $2,148,436 USD |
| Dirk Brinckman | Chief Compliance Officer | – | – |
| Elizabeth Forminard | Executive Vice President & Chief Legal Officer | 1971 | – |
| James Swanson | Executive Vice President & Chief Information Officer | 1966 | – |
| Kathryn E. Wengel | Executive Vice President and Chief Technical Operations & Risk Officer | 1966 | – |
| Robert J. Decker Jr. | Controller & Chief Accounting Officer | 1973 | – |
| Ryan Koors | Vice President of Investor Relations | – | – |